10Y UST5.28%+0.19%30Y MTG7.40%+1.65%SOFR3.87%-0.26%VNQ$90.12+0.86%XLRE$41.29+1.08%FED FUNDS3.88%
Real Estate Trail
Institutional Press Wire
PR Newswire · Office

CellFiber Opens US Subsidiary in Philadelphia to Accelerate Scalable Manufacturing of iPSC, MSC, and CAR-T Cell Therapies

Via PR Newswire · October 9, 2026
Compiled by Real Estate Trail Editorial · October 9, 2026

Why this matters

Office continues to trade in two distinct markets: trophy assets in walkable submarkets that are leasing at or near record rents, and commodity Class B and C buildings where the basis is still resetting. Underwriting on the latter has moved toward replacement-cost-minus, with credit underwriting now leaning on tenant covenant and remaining lease term rather than mark-to-market expectations. For LP-positioned capital, the read-through is that the bifurcation is now a structural feature of the sector, not a cycle to wait out.

Editorial analysis · Real Estate Trail Editorial

On the RET wire

Computed from Real Estate Trail’s own tracked coverage

Excerpt from PR Newswire:
New office and laboratory at CIC Philadelphia will support US biopharma companies, CDMOs, and research institutions developing cell and gene therapies (CGT) and advanced therapy medicinal products (ATMPs) in adopting…
Read the full article at PR Newswire →

External link. Real Estate Trail does not republish source content.

Related coverage — Office